Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray

Acta Pharmacologica Sinica

Volumn 25, Issue 10, 2004, Pages 1327-1333

  Gao, Xue Qin ^a,b   Han, Jin Xiang ^a   Huang, Hai Yan ^a   Yan, Shi ^a   Song, Chang Zheng ^a   Huang, Hai Nan ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Aspirin; cDNA microarray; Gene expression; Neoplasm metastasis; Ovarian neoplasms

Indexed keywords

ACETYLSALICYLIC ACID; CELL ADHESION MOLECULE; GROWTH FACTOR; REAGENT;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; ONCOGENE; OVARY CANCER; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ASPIRIN; CYCLOOXYGENASE INHIBITORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 5444243700     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Oshima M, DinchukJ E, Kargman SL, Oshima H, Hancock B, et al. Suppression of intestinal polyposis in APC delta 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996; 87: 803-9.
2. Gao XQ, Sun SL, Sun HB, Sun FL, Zhang WD, Song SQ, et al. Case control study of the preventive effects of NSAIDs on adenoma, colon and rectal cancer. Chin J Prev Med 2002; 3: 332-5.
3. Goel A, Chang DK, Ricciardiello, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003; 9: 383-90.
4. DNA precipitations/Preparation of DNA samples. [Last Update, December 1999] [Bioinformatics Manual]. Available from: http://cmgm.stanford.edu/pbrown/ protocols/2_DNA.html
5. Post-processing of arrays/Experimental Protocols [updated September 1999] [BioinformaticsManual]http://www.cmgm.stanford.edu/pbrown/protocols/ 3_post_process.html
6. Hasseman J. Aminoallyl labeling of RNA for microarray./ Protocols[The institute of Genome research][Reversion level 2, Effective 3/4/02] Available from:http://pga.tigr.org/protocols.shtml)
7. Yang IV, Chen E, Hasseman JP, Liang W, Frank BC et al. Within the fold: assessing differential expression measures and reproductivity in microarray assays. Genome Biol 2002; 3: 1-12.
8. Wang HY, Liu SH, Zhang M. Gene expression profiles changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin 2003; 24: 646-50.
9. Du ZY, Li XY, Li YC, Wang SY. Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray. Acta Pharmacol Sin 2003; 24: 864-72.
10. Jin W, Qu LF, Min P, Chen S, Li H, et al. Identification of genes responsive to apoptosis in HL60 cells. Acta Pharmacol Sin 2004; 25: 319-26.
11. Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, et al. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 2003; 20: 19-24.
12. Iizaka M, Furukawa Y, Tsunoda T, Akashi H, Ogawa M, et al. Expression Profiles of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Com 2002; 292: 498-512.
13. Huang SG, Kong BH, Ma YY, Jiang S. Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line. Ai Zheng 2002; 21: 863-7.
14. Yi S, Guangqi H, Guoli H. The association of the expression of MTA1, nm23H1 with the invasion, metastasis of ovarian carcinoma. Chin Med Sci J 2003; 18: 87-92.
15. Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, et al. The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep 2003; 10: 599-604.
16. Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278: 42560-8.
17. Wang S, Yan-Neale Y, Fischer D, Zeremski M, Cai R, et al. Histone deacetylase 1 represses the small GTPase RhoB expression in human non-small lung carcinoma cell line. Oncogene 2003; 22: 6204-13.
18. Lagger G, Doetzlhofer A, Schuettengruber B, Haidweger E, Simboeck E, et al. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol 2003; 23: 2669-79.
19. Champelovier P, Boucard N, Levacher G, Simon A, Seigneurin D, et al. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis. Urol Res 2002; 30: 301-9.
20. Li Y, Rizvi SM, Ranson M, Allen BJ. 213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model. Br J Cancer 2002; 86: 1197-203.
21. Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, et al. Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Mol Cell Endocrinol 2000; 159: 63-77.